Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday. Pfizer's offer for the San Francisco-based Medivation goes far beyond the company's market value of $11.1 billion. The boards of directors of both companies have unanimously approved the merger, the statement said. "The proposed acquisition of Medivation is expected to immediately accelerate revenue growth and drive overall earnings growth potential for Pfizer," said Ian Read, Pfizer chairman and chief executive officer. |
|
GMT 14:12 2018 Tuesday ,23 January
Oscar best director nomineesGMT 14:09 2018 Tuesday ,23 January
Oscar best actress nomineesGMT 14:06 2018 Tuesday ,23 January
Oscar best actor nomineesGMT 13:58 2018 Tuesday ,23 January
Oscar best foreign film nomineesGMT 20:03 2018 Monday ,22 January
Eurozone approves 6.7-bln-euro bailout tranche for GreeceGMT 20:00 2018 Monday ,22 January
Trump to travel to Davos as shutdown deal reached: W.HouseGMT 19:57 2018 Monday ,22 January
Democrats to vote to reopen US government: SchumerGMT 19:53 2018 Monday ,22 January
Afrin clashes kill 54 Syrian Kurd and pro-Turkey fighters: monitorMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor